InfuSystem Holdings, Inc (INFU) stock
INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 13/303% above fair value
$14.06−0.61 (-4.16%)
Close on Nov 19, 2026Market cap $280.04MP/E 34.3Yield –
InfuSystem net income
Net income is the profit left for shareholders after every expense, interest and tax.
InfuSystem's net income for the twelve months ending Jun 30, 2026 was $8.54M, up 68.4% year over year. For fiscal 2025 it was $6.63M, up 182.6% from the year before. Over ten years it grew 9.1% a year on average. The highest annual figure on record is $17.33M in fiscal 2020.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.63M | +182.6% |
| FY2024 | Dec 31, 2024 | $2.35M | +168.9% |
| FY2023 | Dec 31, 2023 | $872.00K | +4744.4% |
| FY2022 | Dec 31, 2022 | $18.00K | -98.7% |
| FY2021 | Dec 31, 2021 | $1.42M | -91.8% |
| FY2020 | Dec 31, 2020 | $17.33M | +1173.5% |
| FY2019 | Dec 31, 2019 | $1.36M | – |
| FY2018 | Dec 31, 2018 | -$1.10M | – |
| FY2017 | Dec 31, 2017 | -$20.71M | – |
| FY2016 | Dec 31, 2016 | -$222.00K | -108.0% |
| FY2015 | Dec 31, 2015 | $2.79M | -17.0% |
| FY2014 | Dec 31, 2014 | $3.36M | +101.1% |
| FY2013 | Dec 31, 2013 | $1.67M | – |
| FY2012 | Dec 31, 2012 | -$1.49M | – |
| FY2011 | Dec 31, 2011 | -$45.44M | – |
| FY2010 | Dec 31, 2010 | -$1.85M | -339.3% |
| FY2009 | Dec 31, 2009 | $774.00K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.23M | +24.3% |
| Q1 FY2026 | Mar 31, 2026 | $1.02M | – |
| Q4 FY2025 | Dec 31, 2025 | $2.04M | +118.2% |
| Q3 FY2025 | Sep 30, 2025 | $2.26M | +25.0% |
| Q2 FY2025 | Jun 30, 2025 | $2.60M | +262.5% |
| Q1 FY2025 | Mar 31, 2025 | -$267.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $933.00K | +1195.8% |
| Q3 FY2024 | Sep 30, 2024 | $1.81M | +162.3% |
| Q2 FY2024 | Jun 30, 2024 | $717.00K | +64.8% |
| Q1 FY2024 | Mar 31, 2024 | -$1.11M | – |
| Q4 FY2023 | Dec 31, 2023 | $72.00K | -32.7% |
| Q3 FY2023 | Sep 30, 2023 | $689.00K | +55.5% |
| Q2 FY2023 | Jun 30, 2023 | $435.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$324.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $107.00K | -72.4% |
| Q3 FY2022 | Sep 30, 2022 | $443.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$164.00K | -120.0% |
| Q1 FY2022 | Mar 31, 2022 | -$368.00K | -155.7% |
| Q4 FY2021 | Dec 31, 2021 | $387.00K | -96.4% |
| Q3 FY2021 | Sep 30, 2021 | -$448.00K | -115.2% |
| Q2 FY2021 | Jun 30, 2021 | $820.00K | -80.2% |
| Q1 FY2021 | Mar 31, 2021 | $661.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $10.67M | +1225.5% |
| Q3 FY2020 | Sep 30, 2020 | $2.94M | +159.0% |
| Q2 FY2020 | Jun 30, 2020 | $4.14M | +986.6% |
| Q1 FY2020 | Mar 31, 2020 | -$418.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $805.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $1.14M | – |
| Q2 FY2019 | Jun 30, 2019 | $381.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$960.00K | -570.6% |
| Q4 FY2018 | Dec 31, 2018 | -$275.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$519.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$505.00K | – |
| Q1 FY2018 | Mar 31, 2018 | $204.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$17.99M | – |
| Q3 FY2017 | Sep 30, 2017 | -$129.00K | -330.4% |
| Q2 FY2017 | Jun 30, 2017 | -$1.11M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.48M | – |
| Q4 FY2016 | Dec 31, 2016 | -$472.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $56.00K | – |
See a number that looks wrong?